Ana Paula Martins

PhD (1995) in Pharmacy (Clinical Pharmacy), Universidade de Lisboa
Assistant Professor, Social Pharmacy, Faculdade de Farmácia, Universidade de Lisboa

Faculdade de Farmácia, Universidade de Lisboa — Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal

T (+351) 217 946 400
F (+351) 217 946 470
Researcher ID D-9049-2014
Group Researcher ID B-4101-2014
Scopus Author ID 13807783500

Research Interests

Martins is part of a team that investigate real-life use of medicines from a societal and population level to an individual level. Therefore, epidemiologic studies that aimed to determine effectiveness in clinical real world practice and post-authorization safety data are her major interests. Additionally, risk management and adherence to drug therapy are included in projects under development as key variables for rational drug usage.

Selected Publications

Carvalho M, Sepodes B, Martins AP. Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework. Front Med (Lausanne) 2017; 4: 182.

Marques RP, Duarte GS, Sterrantino C, Pais HL, Quintela A, Martins AP, Costa J. Triplet (FOLFOXIRI) versus doublet (FOLFOX or FOLFIRI) backbone chemotherapy as first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol 2017; 118: 54-62.

Gonçalves E, Marcelo A, Vilão S, Aranda da Silva J, Martins AP. Non-prescription medicinal products dispensed exclusively in the pharmacy: an underused access opportunity in Portugal? Drugs and Therapy Perspectives 2016; 32: 488-498.

Duarte M, Ferreira P, Soares M, Cavaco A, Martins AP. Community Pharmacists’ attitudes towards adverse reaction reporting and their knowledge of the new pharmacovigilance legislation in the Southern Region of Portugal: a mixed methods study. Drugs and Therapy Perspectives 2015; 31: 316–322.

Torre C, Guerreiro J, de Oliveira Martins S, Raposo JF, Martins AP, Leufkens H. Patterns of glucose lowering drugs utilization in Portugal and in the Netherlands. Trends over time. Prim Care Diabetes 2015; 9: 482-489.